Cargando…
Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2
In less than eight months, the COVID-19 (coronavirus disease 2019) caused by the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) virus has resulted in over 20,000,000 confirmed cases and over 700,000 deaths around the world. With the increasing worldwide spreading of this disease, the l...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Research Network of Computational and Structural Biotechnology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448953/ https://www.ncbi.nlm.nih.gov/pubmed/32868983 http://dx.doi.org/10.1016/j.csbj.2020.08.016 |